2269 — Meiji Holdings Share News
0.000.00%
Table: Meiji HD -2021/22 group results
Unit KM Biologics Applied For Marketing Authorization Of Kd-370, Combination Vaccine For Pertussis, Diphtheria, Tetanus, Inactivated Polio And Hib
Table: Meiji HD - 9-MTH group results
Half-year Report
Table: Meiji HD - 6-MTH group results
Table: Meiji HD -Q1 group results
Table: Meiji HD -2020/21 group results
Table: Meiji HD -2020/21 parent results
Japan's KM Biologics begins clinical trial of COVID-19 vaccine candidate
Japanese companies go high-tech in the battle against food waste
Table: Meiji HD - 9-MTH group results
Table: Meiji HD - 6-MTH group results
Table: Meiji HD -Q1 group results
Gargling solution flies off Japan's shelves after governor touts anti-virus effect
Table: Meiji HD -2019/20 group results
Table: Meiji HD -2019/20 parent results
Japfa to sell minority stake in China dairy business to Meiji
Brief: Japfa Ltd Says Entered Into An Agreement With Meiji Co Ltd
Japan stocks rise by most in one month, caution about virus remains